CPT code 53210 represents a definitive oncologic urologic surgery for female patients: complete removal of the urethra with creation of a bladder-to-skin urinary diversion (vesicostomy) to drain urine. This is a major reconstructive and oncologic procedure used when an extensive urethral tumor necessitates urethrectomy and long-term diversion. Nationally, such procedures have implications for surgical resource planning, inpatient stays, and specialized postoperative care.

Key payers addressed in this analysis include Aetna, Blue Cross Blue Shield, Cigna Health, UnitedHealthcare, and Medicare. The publication outlines typical coverage considerations, payment benchmarks where available, and coding context relevant to hospital billing and urology practice.

Readers will find a concise clinical and billing summary, expected site-of-service and service-line context, and an overview of common modifiers and payer considerations where input data exists. The content also highlights areas where input data was not provided and notes that additional diagnosis and taxonomy details are required for complete claims-level adjudication. This national-level briefing is intended to inform revenue cycle, coding, and clinical teams about the clinical intent and billing framing of CPT code 53210 without offering clinical recommendations.